Capstone Therapeutics Corp (CAPS)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Capstone Therapeutics Corp (CAPS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011893
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Capstone Therapeutics Corp (Capstone), formerly OrthoLogic Corp is a biotechnology company that develops novel peptides and other molecules. The company develops novel peptides to support patients with under-served medical conditions. It develops AZX100 and Chrysalin drug platforms. Capstone’s AZX100 is used for the prevention of hypertrophic and keloid scarring and treatment of pulmonary and peridural fibrosis. The company also develops Apo E mimetic peptide molecule AEM-28 and its analogs. It also conducts pre-clinical studies with AZX100 in fibrosis. Capstone is headquartered in Tempe, Arizona, the US.

Capstone Therapeutics Corp (CAPS) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Capstone Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Capstone Therapeutics Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Capstone Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Capstone Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Capstone Therapeutics Corp, Medical Devices Deals, 2011 to YTD 2017 9
Capstone Therapeutics Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Capstone Therapeutics Corp, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Capstone Therapeutics Forms Joint Venture With LipimetiX 11
Capstone Therapeutics Enters Into Co-Development Agreement With BioLineRx 12
Equity Offering 13
Capstone Therapeutics Raises USD1 Million in Private Placement of Shares 13
Capstone Therapeutics to Raise up to USD10 Million in Private Placement of Units 14
Capstone Therapeutics Corp – Key Competitors 15
Capstone Therapeutics Corp – Key Employees 16
Capstone Therapeutics Corp – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Joint Venture 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Capstone Therapeutics Corp, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Capstone Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Capstone Therapeutics Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Capstone Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Capstone Therapeutics Corp, Deals By Therapy Area, 2011 to YTD 2017 8
Capstone Therapeutics Corp, Medical Devices Deals, 2011 to YTD 2017 9
Capstone Therapeutics Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Capstone Therapeutics Forms Joint Venture With LipimetiX 11
Capstone Therapeutics Enters Into Co-Development Agreement With BioLineRx 12
Capstone Therapeutics Raises USD1 Million in Private Placement of Shares 13
Capstone Therapeutics to Raise up to USD10 Million in Private Placement of Units 14
Capstone Therapeutics Corp, Key Competitors 15
Capstone Therapeutics Corp, Key Employees 16
Capstone Therapeutics Corp, Joint Venture 17

★海外企業調査レポート[Capstone Therapeutics Corp (CAPS)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PF Atlantic Petroleum (ATLA DKK):石油・ガス:M&Aディール及び事業提携情報
    Summary P/F Atlantic Petroleum (Atlantic Petroleum) is an oil and gas company that offers development of offshore oil projects. The company's services include exploration, appraisal, development, and production programs. It operates its oil and gas interests in the Norwegian Continental Shelf, the U …
  • Mettler-Toledo International Inc:企業の戦略・SWOT・財務情報
    Mettler-Toledo International Inc - Strategy, SWOT and Corporate Finance Report Summary Mettler-Toledo International Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • DPR Construction Inc:企業の戦略的SWOT分析
    DPR Construction Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Acorn Energy Inc (ACFN):石油・ガス:M&Aディール及び事業提携情報
    Summary Acorn Energy Inc (Acorn) is an energy technology holding company which operates electricity delivery, emergency back-up power generation, and remote monitoring and control systems through its subsidiaries. The company develops and produces sonar systems for the defense, HLS, energy and comme …
  • Netcare Ltd (NTC):企業の財務・戦略的SWOT分析
    Summary Netcare Ltd (Netcare) is a healthcare service provider that offers patient care services. The center provides medical facilities and treatments in the fields of breast care, oncology, orthopedics, renal care, transplants and weight management. Its facilities include medicross centers, netcar …
  • Ebix Inc:企業のM&A・事業提携・投資動向
    Ebix Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ebix Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • Covanta Holding Corp (CVA):電力:M&Aディール及び事業提携情報
    Summary Covanta Holding Corp (Covanta) is a provider of sustainable waste and energy solutions. It generates electricity from its Energy-from-Waste (EfW); and recycles ferrous and non-ferrous metals through its subsidiaries. Its Energy-from-Waste (EfW) facilities convert more than 20 million tons of …
  • Olin Corporation:企業の戦略・SWOT・財務情報
    Olin Corporation - Strategy, SWOT and Corporate Finance Report Summary Olin Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Banco de Sabadell SA:企業のM&A・事業提携・投資動向
    Banco de Sabadell SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Banco de Sabadell SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Dynatronics Corp (DYNT)-医療機器分野:企業M&A・提携分析
    Summary Dynatronics Corp (Dynatronics) is a medical device company that offers rehab technology and equipment solutions. The company offers modalities, hot and cold therapy, clinical accessories, body positioning, sports medicine, orthopedics, hand therapy, strength equipment, treatment tables and r …
  • Gazprom (GAZP):電力:M&Aディール及び事業提携情報
    Summary Gazprom is an integrated global oil and gas company. It carries out the exploration, production, transportation, storage, processing and marketing of natural gas, gas condensate and crude oil. The company also sells gas as a vehicle fuel and participates in the generation and marketing of he …
  • CoreLogic Inc (CLGX):企業の財務・戦略的SWOT分析
    CoreLogic Inc (CLGX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • QEP Resources Inc (QEP):石油・ガス:M&Aディール及び事業提携情報
    Summary QEP Resources Inc (QEP) is an independent oil and natural gas exploration and production company. It has operating interests in Northern Region chiefly in North Dakota, Wyoming and Utah; and Southern Region essentially in Texas and Louisiana. In Northern Region, the company owns productive w …
  • The McClatchy Company (MNI):企業の財務・戦略的SWOT分析
    The McClatchy Company (MNI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Ework Group AB (EWRK):企業の財務・戦略的SWOT分析
    Ework Group AB (EWRK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Orica Ltd:企業の戦略・SWOT・財務分析
    Orica Ltd - Strategy, SWOT and Corporate Finance Report Summary Orica Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Pernix Therapeutics Holdings Inc (PTX)-医療機器分野:企業M&A・提携分析
    Summary Pernix Therapeutics Holdings Inc (Pernix Therapeutics) is a specialty pharmaceutical company that provides generic pharmaceutical products. The company’s portfolio encompasses a fixed dose combination product prescribed to treat acute migraine; an extended-release (XR) opioid agonist that is …
  • Salfacorp SA:企業の戦略・SWOT・財務分析
    Salfacorp SA - Strategy, SWOT and Corporate Finance Report Summary Salfacorp SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • ImmunoGen Inc (IMGN)-医療機器分野:企業M&A・提携分析
    Summary ImmunoGen Inc (ImmunoGen) is a biotechnology company that carries out the development of anticancer therapeutics. The company uses its proprietary antibody-drug conjugates (ADC) technology for the development of the products. It develops products for the treatment of various types of cancer …
  • Global Franchise Group LLC:企業の戦略・SWOT・財務分析
    Global Franchise Group LLC - Strategy, SWOT and Corporate Finance Report Summary Global Franchise Group LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆